Zoledronic Acid Monohydrate CAS 165800-06-6 Purity ≥99.0% API Factory High Purity

Short Description:

Chemical Name: Zoledronic Acid Monohydrate

CAS: 165800-06-6

Appearance: White or Almost Crystalline Powder

Purity: ≥99.0%

A highly potent bisphosphonate and activator of PKC

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer with High Purity and Stable Quality
Chemical Name: Zoledronic Acid Monohydrate
CAS: 165800-06-6
A highly potent bisphosphonate and activator of PKC
API High Quality, Commercial Production

Chemical Properties:

Chemical Name	Zoledronic Acid Monohydrate
CAS Number	165800-06-6
CAT Number	RF-API56
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C5H12N2O8P2
Molecular Weight	290.1
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White or Almost Crystalline Powder
Identification	IR Spectrum; HPLC ChromatogramUV-Vis: There is a maximum absorbance at 210nm
pH	2.0~4.0
Solubility	Sparingly soluble in 0.1N sodium hydroxide solution, slightly soluble in water and 0.1N hydrochloric acid, practically insoluble in ethanol.
Clarity and Color	The solution should be clear and colorless; if opalescent, should not more opalescent than reference suspension 1; if colored, not more intensely colored than Y2
Single Impurity	≤0.50%
Total Impurities	≤1.0%
Loss on Drying	5.0%~8.0%
Chloride	≤0.02%
Phosphate	≤0.50%
Phosphite	≤0.50%
Heavy Metals	≤10ppm
Purity	≥99.0%
Test Standard	Enterprise Standard
Usage	API

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

Zoledronic acid monohydrate is a highly potent bisphosphonate and activator of PKC.Zoledronic acid monohydrate is a heterocyclic bisphosphonate that is considered to have the highest potency of bisphosphonates for suppression of increased bone resorption and has been used in several osteoporosis studies. Zoledronic acid monohydrate is an inhibitor of ASM and FDPS and an activator of PKC. Zoledronic acid (zoledronate) is a bisphosphonate bone resorption inhibitor, an inhibitor of farnesyl diphosphate (FPP) synthase which results in downstream inhibition of osteoclast activity and reduced bone resorption and turnover. It has been used to treat postmenopausal osteoporosis, Paget's disease, hypercalcemia, and along with cancer chemotherapy to treat bone damage caused by cancer that has spread to the bones.